Skip to content

Clinical trials

Phase 1 Hematologic Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Phase: Phase 1 Country / region: United States Clear all

195 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20034
20042
20057
20062
20076
20088
20095
20108
201111
20125
20136
20146
20156
201611
201713
201811
201910
202014
202112
202210
20239
20246
20257
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed104
Recruiting33
Terminated33
Active, not recruiting14
Withdrawn6
Suspended3
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center16
National Cancer Institute (NCI)14
St. Jude Children's Research Hospital7
AbbVie5
Acrotech Biopharma Inc.5
City of Hope Medical Center5
Celgene4
Incyte Corporation4
Janssen Research & Development, LLC4
Amgen3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms195
Leukemia, Myeloid, Acute38
Myelodysplastic Syndromes32
Leukemia, Lymphocytic, Chronic, B-Cell30
Lymphoma28
Lymphoma, Non-Hodgkin27
Multiple Myeloma27
Precursor Cell Lymphoblastic Leukemia-Lymphoma27
Leukemia24
Hodgkin Disease21

Trials

Showing 1 to 25 of 195. Each trial links to its page on Pharma Observatory.

95 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.